Business News • MarketWire • Vicor Technologies' Chief Medical Officer Addresses Meeting of The Royal Melbourne Hospital Cardiologists |
Vicor Technologies' Chief Medical Officer Addresses Meeting of The Royal Melbourne Hospital Cardiologists |
|
|
Vicor Technologies' Chief Medical Officer Addresses Meeting of The Royal Melbourne Hospital Cardiologists
BOCA RATON, FL--(Marketwire - March 24, 2011) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced that Daniel N. Weiss, MD, FACC, Vicor's Chief Medical Officer, addressed a meeting of The Royal Melbourne Hospital cardiologists. Vicor Technologies is a biotechnology company focused on the commercialization of its PD2i AnalyzerT, an innovative, non-invasive diagnostic employing its patented, proprietary PD2i® nonlinear algorithm. The PD2i AnalyzerT enables physicians to accurately risk stratify specific target populations for future pathological events, including diabetics for the presence of diabetic autonomic neuropathy (DAN), cardiovascular disease patients for death resulting from arrhythmia or congestive heart failure, and trauma victims for imminent death absent immediate lifesaving intervention.
View More : http://www.marketwire.com/mw/release.do?id=1416862&sourceType=3
|
|
|